<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Stem Cells</journal-id><journal-id journal-id-type="publisher-id">WJSC</journal-id><journal-title-group><journal-title>World Journal of Stem Cells</journal-title></journal-title-group><issn pub-type="epub">1948-0210</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27822340</article-id><article-id pub-id-type="pmc">5080640</article-id><article-id pub-id-type="other">jWJSC.v8.i10.pg332</article-id><article-id pub-id-type="doi">10.4252/wjsc.v8.i10.332</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Stem/progenitor cells and obstructive sleep apnea syndrome - new insights for clinical applications</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Micheu</surname><given-names>Miruna Mihaela</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rosca</surname><given-names>Ana-Maria</given-names></name></contrib><contrib contrib-type="author"><name><surname>Deleanu</surname><given-names>Oana-Claudia</given-names></name></contrib><aff>Miruna Mihaela Micheu, Department of Cardiology, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania</aff><aff>Ana-Maria Rosca, Department of Regenerative Medicine, &#x0201c;Nicolae Simionescu&#x0201d; Institute for Cellular Biology and Pathology, 050568 Bucharest, Romania</aff><aff>Oana-Claudia Deleanu, &#x0201c;Carol Davila&#x0201d; University of Medicine and Pharmacy, 050474 Bucharest, Romania</aff><aff>Oana-Claudia Deleanu, &#x0201c;Marius Nasta&#x0201d; Institute of Pneumophtisiology Bucharest, 050159 Bucharest, Romania</aff></contrib-group><author-notes><fn><p>Author contributions: All three authors equally contributed to the conception of the paper, the literature review and analysis, drafting and to critically revising and editing the manuscript.</p><p>Correspondence to: Miruna Mihaela Micheu, MD, PhD, Department of Cardiology, Clinical Emergency Hospital of Bucharest, Floreasca street 8, 014461 Bucharest, Romania. <email>mirunamicheu@yahoo.com</email></p><p>Telephone: +4-07-22451755</p></fn></author-notes><pub-date pub-type="ppub"><day>26</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>26</day><month>10</month><year>2016</year></pub-date><volume>8</volume><issue>10</issue><fpage>332</fpage><lpage>341</lpage><history><date date-type="received"><day>19</day><month>4</month><year>2016</year></date><date date-type="rev-recd"><day>25</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9;The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p><!--CREATIVE COMMONS-->Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><abstract><p>Obstructive sleep apnea syndrome (OSAS) is a widespread disorder, characterized by recurrent upper airway obstruction during sleep, mostly as a result of complete or partial pharyngeal obstruction. Due to the occurrence of frequent and regular hypoxic events, patients with OSAS are at increased risk of cardiovascular disease, stroke, metabolic disorders, occupational errors, motor vehicle accidents and even death. Thus, OSAS has severe consequences and represents a significant economic burden. However, some of the consequences, as well as their costs can be reduced with appropriate detection and treatment. In this context, the recent advances that were made in stem cell biology knowledge and stem cell - based technologies hold a great promise for various medical conditions, including respiratory diseases. However, the investigation of the role of stem cells in OSAS is still recent and rather limited, requiring further studies, both in animal models and humans. The goal of this review is to summarize the current state of knowledge regarding both lung resident as well as circulating stem/progenitor cells and discuss existing controversies in the field in order to identify future research directions for clinical applications in OSAS. Also, the paper highlights the requisite for inter-institutional, multi-disciplinary research collaborations in order to achieve breakthrough results in the field.</p></abstract><kwd-group><kwd>Obstructive sleep apnea syndrome</kwd><kwd>Continuous positive airway pressure therapy</kwd><kwd>Lung resident stem/progenitor cells</kwd><kwd>Circulating stem/progenitor cells</kwd><kwd>Lung homeostasis</kwd></kwd-group></article-meta></front><body><p><bold>Core tip:</bold> Obstructive sleep apnea syndrome (OSAS) is a widespread disorder characterized by recurrent upper airway obstruction during sleep, resulting in severe consequences such as increased risk of cardiovascular disease, stroke, metabolic disorders, occupational errors, motor vehicle accidents and even death. However, the consequences and their costs can be reduced with appropriate detection and treatment. The goal of this review is to summarize the current state of knowledge regarding both lung resident as well as circulating stem/progenitor cells and to discuss existing controversies in the field in order to identify future research directions for clinical applications in OSAS.</p><sec><title>INTRODUCTION</title><p>Obstructive sleep apnea syndrome (OSAS) is a prevalent condition with serious undesirable consequences and significant economic burden[<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B4" ref-type="bibr">4</xref>]. It is characterized by recurrent upper airway obstruction during sleep, due mostly to complete or partial pharyngeal obstruction. As a result, sleep fragmentation and repetitive hypoxemia occur, leading to excessive daytime sleepiness, activation of sympathetic nervous system, endothelial dysfunction and hemodynamic changes. Consequently, patients with OSAS are at increased risk of cardiovascular disease, stroke, metabolic disorders, occupational errors, motor vehicle accidents and even death. Health and public consequences, as well as their costs can be reduced with appropriate identification and treatment[<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B5" ref-type="bibr">5</xref>].</p><p>The current treatment includes the use of continuous positive airway pressure (CPAP) or oral devices which must be worn at night to help normal breathing. However, the use of such devises raises the problem of patients&#x02019; adherence to therapy.</p><p>Recent development of scientific methods and understandings of stem cell biology have led to an explosion of interest in stem-cell research; consequently, stem cell - based technologies and therapies soon became one of the most rapidly expanding areas, holding a great promise for various medical conditions.</p><p>The goal of this review is to summarize the current state of knowledge regarding both lung resident as well as circulating stem/progenitor cells and discuss existing controversies in the field in order to identify future research directions for clinical applications in OSAS.</p></sec><sec><title>LUNG RESIDENT STEM/PROGENITOR CELLS</title><p>Several varieties of human lung resident stem/progenitor cells have been isolated and identified both <italic>in vivo</italic> and <italic>in vitro</italic>. Broadly, they comprise three major cell types, which are summarized in Table <xref ref-type="table" rid="T1">1</xref>: Epithelial stem/progenitor cells, endothelial progenitor cells (L-EPCs) and mesenchymal stem cells (L-MSCs).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Human lung resident stem/progenitor cells</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Cell type</bold></td><td rowspan="1" colspan="1"><bold>Cell markers</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Tracheal basal epithelial cells</td><td rowspan="1" colspan="1">NGFR<sup>+</sup>/ITGA6<sup>+</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Type II alveolar cells</td><td rowspan="1" colspan="1">HTII-280<sup>+</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Airway epithelial cells</td><td rowspan="1" colspan="1">CD151<sup>+</sup>/TF<sup>+</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Airway epithelial cells</td><td rowspan="1" colspan="1">SP/CD45<sup>-</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Lung epithelial cells</td><td rowspan="1" colspan="1">c-kit<sup>+</sup> (CD117)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lung epithelial cells</td><td rowspan="1" colspan="1">Ecad/Lgr6<sup>+</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">L-MSCs</td><td rowspan="1" colspan="1">CD73<sup>+</sup>/CD90<sup>+</sup>/CD105<sup>+</sup></td></tr></tbody></table><table-wrap-foot><fn><p>L-MSC: Lung mesenchymal stem cells.</p></fn></table-wrap-foot></table-wrap><sec><title>Epithelial stem/progenitor cells</title><p>Certain cells, which were formerly considered to be differentiated airway or alveolar epithelial cells, have been proved to be able to proliferate and differentiate into other lung epithelial cell types under specific conditions, which suggested that they could be adult lung resident stem/progenitor cells. However, characterization and classification of such cells into a hierarchy could be quite challenging since the terms &#x0201c;stem&#x0201d; and &#x0201c;progenitor&#x0201d; are often used interchangeably[<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>]. Moreover, data describing putative populations of human adult resident epithelial stem/progenitor cells are limited compared with the large body of evidence in animal models. Several cellular markers have been used alone or in various combinations to identify and isolate stem/progenitor cells in adult human lung.</p><p>The first to identify airway epithelial basal cells having stem cell properties in human adult lungs was a group of French scientists in 2007[<xref rid="B8" ref-type="bibr">8</xref>].</p><p>By using fluorescence-activated cell sorting, Hajj and collaborators demonstrated that epithelial basal cells, which resided on human adult airway surface and expressed CD151 and tissue factor were able to generate a fully differentiated mucocilliary and functional airway epithelium both <italic>in vitro</italic> and <italic>in vivo</italic>, while maintaining their self-renewal potential.</p><p>One year later, the existence of a resident side population (SP) cells within the human tracheobronchial epithelium was demonstrated for the first time[<xref rid="B9" ref-type="bibr">9</xref>]. SP cells were identified by verapamil-sensitive efflux of the DNA-binding dye Hoechst 33342. Within SP fraction, CD45<sup>-</sup> cells represented 0.12% &#x000b1; 0.01% of the total epithelial cell population in normal airway. Their epithelial phenotype was confirmed by positive immunohistochemical staining for the epithelial markers cytokeratin-5, E-cadherin, tight junction protein ZO-1 and transcription factor Trp-63 (p63) - mainly isoform &#x00394;Np63. In culture, these cells demonstrated sustained colony-forming and clonogenic capacity as well as well-preserved telomere length over successive passages. Moreover, CD45<sup>-</sup> SP cells were able to generate a multilayered differentiated epithelium in air-liquid interface culture, endorsing their stem cell capacity.</p><p>Shortly after, tracheal basal cells have been isolated based on their expression of the markers nerve growth factor receptor (NGFR) and integrin &#x003b1;6 (ITGA6)[<xref rid="B10" ref-type="bibr">10</xref>]. When cultured under appropriate conditions, NGFR<sup>+</sup>/ITGA6<sup>+</sup> cells gave rise to three-dimensional aggregates (bronchospheres) containing cells positive for transcription factor Trp-63 and cytokeratin 14 (Krt14), luminal cells (Krt8<sup>+</sup>) and also ciliated cells. Hence, human basal cells have been proved to be capable of both self-renewal and generation of differentiated progenies.</p><p>In a recent study, Barkauskas et al[<xref rid="B11" ref-type="bibr">11</xref>] isolated human type II alveolar cells (AT2) using florescence-activated cell sorting based on a biomarker specific to the apical surface of their membrane (HTII-280). When cocultured with fetal human lung fibroblasts, AT2 cells also formed self-renewing three-dimensional colonies (alveolospheres) composed of a single epithelial layer of HTII-280<sup>+</sup> cells.</p><p>A putative population of c-kit<sup>+</sup> human lung stem cells nested in niches in the adult distal airways has been identified and characterized as self-renewing, clonogenic, and multipotent both <italic>in vitro</italic> and <italic>in vivo</italic>. When transplanted into damaged mouse lungs, human c-kit<sup>+</sup> cells not only engrafted, but they were also able to generate human bronchioles, alveoli, and pulmonary vessels structurally and functionally integrated with the host organism[<xref rid="B12" ref-type="bibr">12</xref>]. As appealing as this hypothesis appears - one adult lung cell being capable to give birth to smooth muscle, vasculature, airways and alveoli - it needs further supporting evidence and validation using lineage-tracing during homeostasis and injury[<xref rid="B13" ref-type="bibr">13</xref>].</p><p>Shortly after description of c-kit+ human lung stem cells, the existence of another population of putative stem cells was reported[<xref rid="B14" ref-type="bibr">14</xref>]. These cells were characterized as positive for E-Cadherin and leucine-rich repeat-containing G-protein-coupled receptor 6 (E-Cad/Lgr6<sup>+</sup>) while being a sub-population of ITGA6<sup>+</sup> cells. In culture, clonally derived E-Cad/Lgr6<sup>+</sup> cells formed aggregates capable of <italic>in vitro</italic> indefinite expansion while expressing lung-specific (pulmonary-associated surfactant protein C, Clara cell 10 protein, aquaporin 5), epithelial (E-Cad) and stem cell (Sox9, Lgr5/6, ITGA6) markers. Unlike c-kit<sup>+</sup> cells, E-Cad/Lgr6<sup>+</sup> were not able to differentiate into mesenchymal or endothelial cells. E-Cad/Lgr6+ single cell transplantations into the kidney capsule generated differentiated bronchioalveolar tissue while retaining the ability to self-renew[<xref rid="B14" ref-type="bibr">14</xref>].</p><p>Thus, all these data support the involvement of resident lung stem/progenitor cells in tissue homeostasis, but also in tissue repair after cellular injury.</p></sec><sec><title>L-MSCs</title><p>Several groups have identified human lung resident cells fulfilling criteria for definition of mesenchymal stem cells[<xref rid="B15" ref-type="bibr">15</xref>-<xref rid="B18" ref-type="bibr">18</xref>]. According to Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy criteria, the definition of human MSCs comprises: (1) plastic adherence in standard culture conditions; (2) expression of surface molecules CD73, CD90 and CD105 in the absence of CD34, CD45, HLA-DR, CD14 or CD11b, CD79a, or CD19 surface molecules as assessed by fluorescence-activated cell sorter analysis and (3) a capacity for differentiation into osteoblasts, adipocytes, and chondroblasts <italic>in vitro</italic>[<xref rid="B19" ref-type="bibr">19</xref>]. Besides these established and generally accepted criteria, another marker which was used to identify human L-MSCs was the ATP binding cassette G transporter[<xref rid="B20" ref-type="bibr">20</xref>].</p><p>It is common knowledge that mesenchymal stem cells (MSCs) exhibit high telomerase activity and an extensive secretome that is immunomodulatory, antifibrotic, and trophic for endogenous tissue progenitor cells; this robust evidence supports their role as key players in organ homeostasis and repair following injury, and endorse MSCs as ideal candidates for cell-based therapies. L-MSCs demonstrated characteristics similar to other tissue MSCs including paracrine anti-inflammatory properties, suppression of T cell proliferation as well as the ability to differentiate to myofibroblasts[<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B21" ref-type="bibr">21</xref>].</p><p>Studies conducted so far - both in animal and human lung tissue - identified MSCs niches colocalized with the alveolar capillary network in the distal lung, suggesting that L-MSCs are anatomically similar to adult angioblasts, pericytes and endothelial precursors[<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B23" ref-type="bibr">23</xref>]. The data regarding the perivascular location of L-MSCs are in agreement with previously reported information which indicates that the distribution of MSCs throughout the post-natal organism is related to their existence in a perivascular niche[<xref rid="B24" ref-type="bibr">24</xref>-<xref rid="B26" ref-type="bibr">26</xref>].</p></sec><sec><title>Postnatal endothelial progenitor cells</title><p>It represent a heterogeneous group of precursor cells, which have been isolated from bone marrow, peripheral and umbilical cord blood, as well as vascular wall, participating in both new blood vessel formation and vascular homeostasis[<xref rid="B27" ref-type="bibr">27</xref>-<xref rid="B31" ref-type="bibr">31</xref>].</p><p>Unfortunately, no specific marker for endothelial progenitor cells (EPCs) has been identified yet. Cells considered being EPCs share distinguishing features as high capacity for self-renewal and regeneration, fast proliferating endothelial colony-forming units and angiogenic properties. The quest for identifying tissue resident EPCs has not been an easy one since the difficulty to discriminate circulating EPCs from bone marrow and tissue resident EPCs.</p><p>Currently, the existence of similar cells in the lungs - resident lung EPCs (L-EPCs) - has been highlighted only in animal models. L-EPCs express classical endothelial cell markers (CD31) and display a microvascular phenotype. Furthermore, similarly to circulating and vessel wall-derived EPCs, mouse L-EPCs express CD34, CD133 and VEGFR-2, while rat L-EPCs are negative for CD133. These cells proved to be highly proliferative and capable of renewing the entire hierarchy of endothelial cell growth potentials. Also, L-EPCs are vasculogenic in Matrigel assays <italic>in vitro</italic> and <italic>in vivo</italic>[<xref rid="B32" ref-type="bibr">32</xref>-<xref rid="B34" ref-type="bibr">34</xref>]. These data support the premise that the lung microvasculature is a rich endothelial progenitor niche, with essential role in maintaining vascular homeostasis.</p></sec></sec><sec><title>CIRCULATING STEM/PROGENITOR CELLS</title><p>To this point, mainly two circulating stem/progenitor cell types are envisaged as having a potential for immediate clinical application in relation to OSAS: EPCs and MSCs[<xref rid="B35" ref-type="bibr">35</xref>].</p><sec><title>Circulating EPCs</title><p>As previously mentioned, circulating EPCs are bone marrow derived cells that can be found in peripheral and umbilical cord blood.</p><p>The phenotype of an accurate EPC, the reliable methods to assess EPCs&#x02019; quantity and quality as well as their functional status are still under debate. In a review published in 2005, Khakoo et al[<xref rid="B31" ref-type="bibr">31</xref>] described the EPCs having the following characteristics: (1) they are circulating, bone marrow-derived cells that are functionally and phenotypically distinct from mature endothelial cells; (2) they can differentiate into endothelial cells <italic>in vitro</italic>, as assessed by expression profiles and functional characteristics and (3) they can contribute to <italic>in vivo</italic> vasculogenesis and/or vascular homeostasis.</p><p>However, since their first mention[<xref rid="B27" ref-type="bibr">27</xref>], the definition of EPCs has come under serious dispute, taking into consideration that further studies have shown that the term &#x0201c;EPC&#x0201d; do not define a single cell type, but rather describe various cell types able to differentiate into the endothelial lineage[<xref rid="B36" ref-type="bibr">36</xref>-<xref rid="B40" ref-type="bibr">40</xref>].</p><p>According to the timing of their growth in culture, there are at least two morphologically and functionally different endothelial cell populations that originate from circulating mononuclear cells: The so-called &#x0201c;early&#x0201d; and &#x0201c;late&#x0201d; EPCs. The early EPCs are derived from the monocytes and express hematopoietic markers such as CD45, CD14, CD11b and CD11c, while the late EPCs, which are believed to be a subset of CD14<sup>-</sup> CD34<sup>-</sup> KDR<sup>-</sup> cells do not express CD45 or CD14. Although these two types of cells are different-originated with distinct function <italic>in vitro</italic>, both of them contribute to <italic>in vivo</italic> neovascularization in animal models of ischemia[<xref rid="B41" ref-type="bibr">41</xref>-<xref rid="B43" ref-type="bibr">43</xref>].</p><p>The existence of two different EPCs populations in human peripheral blood, one with high proliferative capacity and the other with lower proliferative capacity, both with comparable efficacy in neovascularization in an ischemic limb model was demonstrated also by the work of Hur et al[<xref rid="B44" ref-type="bibr">44</xref>]. Early EPCs had spindle shape, their growth in culture peaked at 2 to 3 wk and died at 4 wk, whereas late EPCs with cobblestone shape appeared after 2 to 3 wk in culture, showed exponential growth at 4 to 8 wk, and lived up to 12 wk. Late EPCs was different from early EPCs, having strong expression of VE-cadherin, Flt-1, KDR, and vWF. Late EPCs produced more nitric oxide, incorporated more readily into human umbilical vein endothelial cells monolayer, and formed capillary tubes better than early EPCs. However, early EPCs had a more pronounced <italic>in vitro</italic> capacity to secrete angiogenic cytokines [such as and vascular endothelial growth factor (VEGF), IL8] in comparison to late EPCs.</p><p>The final touch in the field (till this moment) was added by Sieveking and collaborators, who emphasized the &#x0201c;strikingly different angiogenic properties of different EPCs: Late-outgrowth endothelial cells directly participate in tubulogenesis, whereas early EPCs augment angiogenesis in a paracrine fashion, with implications for optimizing cell therapies for neovascularisation&#x0201d;[<xref rid="B45" ref-type="bibr">45</xref>]. As for surface markers, their results are consistent with the previous studies, endothelial antigens (<italic>e.g</italic>., CD31, CD146, VEGFR-2) being expressed by both early and late EPCs. These two populations could be discriminated by CD14 and CD45 expression, with early EPCs showing high expression of these markers (over 95%) whereas late EPCs did not express either maker.</p><p>EPCs are able to migrate to the site of injury and participate directly and indirectly to the development of new blood vessels, therefore having a key role in the maintenance of endothelium integrity and function[<xref rid="B46" ref-type="bibr">46</xref>]. Moreover, these cells play an essential role not only in physiological neovascularization, but also in pathological conditions (wound healing, tissue regeneration in ischemia, tissue remodeling in diabetes mellitus and heart failure, growth of tumors)[<xref rid="B47" ref-type="bibr">47</xref>-<xref rid="B50" ref-type="bibr">50</xref>]. Studies conducted so far have shown that EPCs&#x02019; mobilization from the bone marrow is governed by a multifaceted interaction between cytokines/chemokines, proteinases and cell adhesion molecules[<xref rid="B51" ref-type="bibr">51</xref>-<xref rid="B55" ref-type="bibr">55</xref>], many of them having abnormal expression in OSAS[<xref rid="B56" ref-type="bibr">56</xref>-<xref rid="B58" ref-type="bibr">58</xref>].</p><p>In order to minimize the potential interfering factors, studies on EPCs in OSAS have been conducted on subjects free of any other known cardiovascular risk factors. OSAS patients and healthy controls were well-matched for age, sex and body mass index; moreover, they had similar blood pressure, fasting blood glucose and total cholesterol levels[<xref rid="B59" ref-type="bibr">59</xref>].</p><p>Even though, the cumulative results regarding the level of circulating EPCs in OSAS are still under debate, since existing studies have reported heterogeneous data (Table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Circulating endothelial progenitor cells studies in patients with obstructive sleep apnea syndrome</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Ref</bold>.</td><td rowspan="1" colspan="1"><bold>Study design</bold></td><td rowspan="1" colspan="1"><bold>EPCs phenotype</bold></td><td rowspan="1" colspan="1"><bold>OSAS effect on EPCs number</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">de la Pe&#x000f1;a et al[<xref rid="B60" ref-type="bibr">60</xref>]</td><td rowspan="1" colspan="1">Adults, men, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup>VEGFR2<sup>+</sup></td><td rowspan="1" colspan="1">Reduced number</td></tr><tr><td align="left" rowspan="1" colspan="1">Jelic et al[<xref rid="B61" ref-type="bibr">61</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup>CD133<sup>+</sup>VEGFR2<sup>+</sup></td><td rowspan="1" colspan="1">Reduced number</td></tr><tr><td align="left" rowspan="1" colspan="1">Jelic et al[<xref rid="B62" ref-type="bibr">62</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup>CD133<sup>+</sup>VEGFR2<sup>+</sup></td><td rowspan="1" colspan="1">Reduced number</td></tr><tr><td align="left" rowspan="1" colspan="1">Murri et al[<xref rid="B63" ref-type="bibr">63</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD45<sup>-</sup>CD34<sup>+</sup>CD133<sup>+</sup>VEGFR2<sup>+</sup></td><td rowspan="1" colspan="1">Reduced number</td></tr><tr><td align="left" rowspan="1" colspan="1">Kheirandish-Gozal et al[<xref rid="B64" ref-type="bibr">64</xref>]</td><td rowspan="1" colspan="1">Children, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup>CD133<sup>+</sup>VEGFR2<sup>+</sup></td><td rowspan="1" colspan="1">Reduced number</td></tr><tr><td align="left" rowspan="1" colspan="1">Martin et al[<xref rid="B65" ref-type="bibr">65</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup>CD133<sup>+</sup>CD45<sup>dim</sup></td><td rowspan="1" colspan="1">Unchanged number</td></tr><tr><td align="left" rowspan="1" colspan="1">Yun et al[<xref rid="B66" ref-type="bibr">66</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, endothelial colony forming units assay</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Unchanged number</td></tr><tr><td rowspan="2" align="left" colspan="1">Simpson et al[<xref rid="B67" ref-type="bibr">67</xref>]</td><td rowspan="2" colspan="1">Adults, men, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup>KDR<sup>+</sup></td><td rowspan="2" colspan="1">Unchanged number</td></tr><tr><td rowspan="1" colspan="1">CD45<sup>-</sup>CD34<sup>+</sup>KDR<sup>+</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Kizawa et al[<xref rid="B68" ref-type="bibr">68</xref>]</td><td rowspan="1" colspan="1">Adults, men, flow cytometry</td><td rowspan="1" colspan="1">CD133<sup>+</sup>CD34<sup>+</sup>CD202b<sup>+</sup>CD45<sup>-</sup></td><td rowspan="1" colspan="1">Increased number</td></tr><tr><td align="left" rowspan="1" colspan="1">Lui et al[<xref rid="B69" ref-type="bibr">69</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup></td><td rowspan="1" colspan="1">Increased number</td></tr><tr><td align="left" rowspan="1" colspan="1">Chou et al[<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup></td><td rowspan="1" colspan="1">Increased number</td></tr></tbody></table><table-wrap-foot><fn><p>EPC: Endothelial progenitor cell; OSAS: Obstructive sleep apnea syndrome.</p></fn></table-wrap-foot></table-wrap><p>Five studies out of 11 reported a decrease in EPCs in OSAS patients comparative with healthy controls, either adults or children[<xref rid="B60" ref-type="bibr">60</xref>-<xref rid="B64" ref-type="bibr">64</xref>]. In contrast with these findings, data from quite similar studies showed that patients suffering of this medical condition had unchanged[<xref rid="B65" ref-type="bibr">65</xref>-<xref rid="B67" ref-type="bibr">67</xref>] or even increased number of circulating EPCs in peripheral blood compared with the control group[<xref rid="B68" ref-type="bibr">68</xref>-<xref rid="B70" ref-type="bibr">70</xref>].</p><p>It is only natural to ask ourselves why there is so much divergence in apparently similar studies. Some possible reasons concerning this heterogeneity have been identified[<xref rid="B59" ref-type="bibr">59</xref>]: (1) Different studies measured circulating EPCs by means of different methods: Flow cytometry <italic>vs</italic> endothelial colony forming units assay; (2) Different investigators used different marker combinations for the assessment of EPCs (Table <xref ref-type="table" rid="T2">2</xref>); (3) Different participants: Adults <italic>vs</italic> children or male <italic>vs</italic> men and women; (4) Small number of subjects enrolled, as well as the small number of EPCs circulating in peripheral blood.</p><p>Also, taking into consideration the complexity of pathogenic mechanisms involved, it is very possible that - depending upon disease severity and duration - certain mechanisms to prevail.</p><p>Potential molecular mechanisms through which OSAS has effects on EPCs were reviewed in the exhaustive work of Wang et al[<xref rid="B59" ref-type="bibr">59</xref>]. Briefly, intermittent hypoxia and sleep fragmentation which are key features of OSAS act as triggers of oxidative stress, systemic inflammation and sympathetic activation.</p><p>While most mechanisms lead to decreased EPCs mobilization and increased cell apoptosis, there are others with stimulating effect as regards mobilization through hypoxia inducible factor 1 (HIF-1) regulatory pathway activation and upregulation of proangiogenic factors including vascular endothelial growth factor, stromal-derived factor-1 and erythropoietin.</p><p>But what is the effect of treatment on EPCs? The current gold standard treatment for OSAS is CPAP therapy, which has been demonstrated not only to significantly improve sleep quality, reduce the risk of comorbidities and increase patient quality of life, but also to minimize risks of accidents and injuries[<xref rid="B71" ref-type="bibr">71</xref>-<xref rid="B74" ref-type="bibr">74</xref>]. By effectively diminishing the intermittent hypoxia episodes, CPAP can prevent the activation of pathogenic mechanism that has been shown to affect EPCs number and function.</p><p>As depicted in Table <xref ref-type="table" rid="T3">3</xref>, CPAP therapy had opposite consequences on circulating EPCs: Normalization in patients having decreased levels[<xref rid="B61" ref-type="bibr">61</xref>-<xref rid="B63" ref-type="bibr">63</xref>] - or lessening in patients with high levels[<xref rid="B68" ref-type="bibr">68</xref>,<xref rid="B70" ref-type="bibr">70</xref>]. One study reported unchanged values before and after treatment[<xref rid="B67" ref-type="bibr">67</xref>]. Of course, there is an essential factor to consider when assessing rehabilitation effect: Patients&#x02019; adherence to prescribed therapy. Adherence to CPAP treatment is still a critical and complex issue, subjected to the influence of a wide array of factors[<xref rid="B75" ref-type="bibr">75</xref>-<xref rid="B79" ref-type="bibr">79</xref>]. Poor adherence to CPAP is generally acknowledged as a major limiting factor in treating OSAS, with a negative impact on therapeutic success[<xref rid="B80" ref-type="bibr">80</xref>-<xref rid="B82" ref-type="bibr">82</xref>]. Studies conducted in the 1990s or even recently, revealed that approximately 30%-50% of OSAS patients rejected CPAP immediately, the proportion of noncompliant patients reaching 80% within a year[<xref rid="B83" ref-type="bibr">83</xref>-<xref rid="B86" ref-type="bibr">86</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Circulating endothelial progenitor cells studies in patients with obstructive sleep apnea syndrome treated by continuous positive airway pressure</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Ref</bold>.</td><td rowspan="1" colspan="1"><bold>Study design</bold></td><td rowspan="1" colspan="1"><bold>EPCs phenotype</bold></td><td rowspan="1" colspan="1"><bold>CPAP effect on EPCs number</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Jelic et al[<xref rid="B61" ref-type="bibr">61</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup>CD133<sup>+</sup>VEGFR2<sup>+</sup></td><td rowspan="1" colspan="1">Normalized after 4 wk of CPAP</td></tr><tr><td align="left" rowspan="1" colspan="1">Jelic et al[<xref rid="B62" ref-type="bibr">62</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup>CD133<sup>+</sup>VEGFR2<sup>+</sup></td><td rowspan="1" colspan="1">Normalized after 4 wk of CPAP</td></tr><tr><td align="left" rowspan="1" colspan="1">Murri et al[<xref rid="B63" ref-type="bibr">63</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD45<sup>-</sup>CD34<sup>+</sup>CD133<sup>+</sup>VEGFR2<sup>+</sup></td><td rowspan="1" colspan="1">Values returned to control values after 1 mo of CPAP</td></tr><tr><td align="left" rowspan="1" colspan="1">Simpson et al[<xref rid="B67" ref-type="bibr">67</xref>]</td><td rowspan="1" colspan="1">Adults, men, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup>KDR<sup>+</sup> CD34<sup>+</sup>KDR<sup>+</sup>CD45<sup>-</sup></td><td rowspan="1" colspan="1">Unchanged</td></tr><tr><td align="left" rowspan="1" colspan="1">Kizawa et al[<xref rid="B68" ref-type="bibr">68</xref>]</td><td rowspan="1" colspan="1">Adults, men, flow cytometry</td><td rowspan="1" colspan="1">CD133<sup>+</sup>CD34<sup>+</sup>CD202b<sup>+</sup>CD45<sup>-</sup></td><td rowspan="1" colspan="1">Values decreased after 12 wk of CPAP treatment</td></tr><tr><td align="left" rowspan="1" colspan="1">Chou et al[<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">Adults, both genders, flow cytometry</td><td rowspan="1" colspan="1">CD34<sup>+</sup></td><td rowspan="1" colspan="1">Mobilization ratio in patients with OSAS tended to decline</td></tr></tbody></table><table-wrap-foot><fn><p>EPC: Endothelial progenitor cell; OSAS: Obstructive sleep apnea syndrome; CPAP: Continuous positive airway pressure.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Circulating MSCs</title><p>MSCs are located mainly in the bone marrow, but are also found in various tissues and organs. When stimulated by specific signals, these cells are mobilized from their perivascular niche into peripheral blood and home to the target tissues where they contribute to local tissue regeneration and homeostasis[<xref rid="B87" ref-type="bibr">87</xref>-<xref rid="B90" ref-type="bibr">90</xref>].</p><p>There is only little evidence regarding the number and function of circulating MSCs in peripheral blood in OSAS; only 3 studies in animal models[<xref rid="B91" ref-type="bibr">91</xref>-<xref rid="B93" ref-type="bibr">93</xref>], and a single one in humans, in which circulating MSCs could not be detected, probably because their very low number[<xref rid="B94" ref-type="bibr">94</xref>].</p><p>In an acute rat model of recurrent airway obstructions mimicking OSAS, Carreras et al[<xref rid="B91" ref-type="bibr">91</xref>] demonstrated early release of MSCs into circulation, higher mobility, increased adhesion to endothelial cells and enhanced endothelial wound repair in rats subjected to recurrent obstructive apneas (15 s apnea/min for 3 h), as compared to the number observed in control animals under normoxia[<xref rid="B93" ref-type="bibr">93</xref>]. In addition, in the group of apneic rats subjected to MSCs intravenous injection, MSCs triggered an early systemic anti-inflammatory response by decreasing levels of interleukin-1 beta (IL-1&#x003b2;)[<xref rid="B92" ref-type="bibr">92</xref>]. This property of MSCs has been confirmed in a chronic murine model of OSAS in which atrial fibrosis has been inhibited by the intravenous administration of MSCs as a result of normalization of IL-1&#x003b2; plasma levels[<xref rid="B95" ref-type="bibr">95</xref>].</p><p>Considering all this data, one of the main benefits of MSCs therapy in OSAS patients could be the local and systemic anti-inflammatory effect. Besides this, exposure to hypoxia upregulates microRNA-486 (miR-486) expression in MSCs resulting in increased production of angiogenic factors (hepatocyte growth factor and VEGF), increased proliferation and reduced apoptosis[<xref rid="B96" ref-type="bibr">96</xref>].</p><p>One of the challenges for cell therapy is that it requires high numbers and good quality of stem cells. Among factors impairing the quantity and quality of autologous MSCs is age which is associated with progressive loss of cell proliferation and differentiation potential.</p><p>Nevertheless, MSCs cultured under hypoxic condition exhibited enriched self-renewing and proliferation capacity even in aged donors compared to normal condition. It was shown that, at low O<sub>2</sub> concentration (such as 1% O<sub>2</sub>) MSCs are resistant to apoptosis and do not lose their beneficial paracrine activity, suggesting that they could be transplanted in hypoxia affected tissues without losing their viability or therapeutic properties[<xref rid="B97" ref-type="bibr">97</xref>]. In a very recent study, different profiles of hypoxia-inducible miRNA signatures between young and aged MSCs have been identified and demonstrated to target transcriptional activity leading to enhanced cell proliferation and migration, but also to decrease in growth arrest and apoptosis through the activation of multiple signaling pathways. According to donor&#x02019;s age and culture conditions a therapeutic potential hierarchy of MSCs was established as follows: Young (hypoxia) &#x0003e; young (normoxia) &#x0003e; old aged (hypoxia) &#x0003e; old aged (normoxia)[<xref rid="B98" ref-type="bibr">98</xref>].</p><p>Another particular aspect concerning MSCs therapeutic applications is related to their hypoimmunogenic or &#x0201c;immune privileged&#x0201d; status; this unique feature endorses them as suitable candidates for allogeneic transplant.</p><p>Human MSCs display low levels of human leukocyte antigen (HLA) major histocompatibility complex class I, lack major histocompatibility complex class II expression and do not express costimulatory molecules CD40, CD80 and CD86[<xref rid="B99" ref-type="bibr">99</xref>-<xref rid="B101" ref-type="bibr">101</xref>]. Furthermore, these cells have been shown to have immunomodulatory effects on both the innate and adaptive immune system, being able to suppress the activity of a variety of immune cells, including natural killer T cells, dendritic cells, neutrophils, monocytes, macrophages, B and T cells[<xref rid="B102" ref-type="bibr">102</xref>-<xref rid="B105" ref-type="bibr">105</xref>].</p></sec></sec><sec><title>PERSPECTIVES</title><p>Research regarding the role of SC in OSAS pathology and their potential use in OSAS treatment is still recent and quite limited, requiring further studies in both animal models and humans. Future directions and recommendations to achieve advanced understanding of mechanisms of lung homeostasis and repair have been proposed during expert meetings[<xref rid="B106" ref-type="bibr">106</xref>-<xref rid="B108" ref-type="bibr">108</xref>]. In this regard, it is necessary to identify additional cell surface markers to characterize lung cell populations but also to refine the nomenclature used for resident and circulating lung stem cells. Additional studies are required to identify and characterize resident lung stem/progenitors cells and their niches comparatively between different lung compartments and also regulatory pathways guiding their behavior. Mechanisms of recruitment, mobilization and homing of circulating or transplanted cells to various lung compartments have to be elucidated based on disease-specific models (including large animal models).</p><p>Maybe the most important take - home messages are those emphasizing the requisite for inter-institutional, multi-disciplinary research collaborations and consortiums. A successful stem cell research requires state-of-the art infrastructure and vast resources. Connecting with existing networks, nonprofit respiratory disease foundations and industry could accelerate clinical applications. Also, joining other clinical trials in related disciplines (<italic>e.g</italic>., cardiovascular disease) would provide valuable data for development of stem cell research-derived therapeutics.</p><p>Last but not least, obtained information must be largely disseminated through existing core services, facilities and web links.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>Conflict-of-interest statement: Authors declare no conflict of interests for this article. No financial support.</p></fn><fn><p>Manuscript source: Invited manuscript</p></fn><fn><p>Specialty type: Cell and tissue engineering</p></fn><fn><p>Country of origin: Romania</p></fn><fn><p>Peer-review report classification</p></fn><fn><p>Grade A (Excellent): 0</p></fn><fn><p>Grade B (Very good): B</p></fn><fn><p>Grade C (Good): C</p></fn><fn><p>Grade D (Fair): 0</p></fn><fn><p>Grade E (Poor): 0</p></fn><fn><p>Peer-review started: April 19, 2016</p></fn><fn><p>First decision: June 12, 2016</p></fn><fn><p>Article in press: August 16, 2016</p></fn><fn><p>P- Reviewer: Valenti MT, Yao CL S- Editor: Qiu S L- Editor: A E- Editor: Wu HL</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>T</given-names></name><name><surname>Palta</surname><given-names>M</given-names></name><name><surname>Dempsey</surname><given-names>J</given-names></name><name><surname>Skatrud</surname><given-names>J</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Badr</surname><given-names>S</given-names></name></person-group><article-title>The occurrence of sleep-disordered breathing among middle-aged adults</article-title><source>N Engl J Med</source><year>1993</year><volume>328</volume><fpage>1230</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1056/NEJM199304293281704</pub-id><pub-id pub-id-type="pmid">8464434</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarasiuk</surname><given-names>A</given-names></name><name><surname>Reuveni</surname><given-names>H</given-names></name></person-group><article-title>The economic impact of obstructive sleep apnea</article-title><source>Curr Opin Pulm Med</source><year>2013</year><volume>19</volume><fpage>639</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1097/MCP.0b013e3283659e1e</pub-id><pub-id pub-id-type="pmid">24060978</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isetta</surname><given-names>V</given-names></name><name><surname>Negr&#x000ed;n</surname><given-names>MA</given-names></name><name><surname>Monasterio</surname><given-names>C</given-names></name><name><surname>Masa</surname><given-names>JF</given-names></name><name><surname>Feu</surname><given-names>N</given-names></name><name><surname>&#x000c1;lvarez</surname><given-names>A</given-names></name><name><surname>Campos-Rodriguez</surname><given-names>F</given-names></name><name><surname>Ruiz</surname><given-names>C</given-names></name><name><surname>Abad</surname><given-names>J</given-names></name><name><surname>V&#x000e1;zquez-Polo</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial</article-title><source>Thorax</source><year>2015</year><volume>70</volume><fpage>1054</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2015-207032</pub-id><pub-id pub-id-type="pmid">26310452</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurado-G&#x000e1;mez</surname><given-names>B</given-names></name><name><surname>Guglielmi</surname><given-names>O</given-names></name><name><surname>Gude</surname><given-names>F</given-names></name><name><surname>Buela-Casal</surname><given-names>G</given-names></name></person-group><article-title>Workplace accidents, absenteeism and productivity in patients with sleep apnea</article-title><source>Arch Bronconeumol</source><year>2015</year><volume>51</volume><fpage>213</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.arbres.2014.07.003</pub-id><pub-id pub-id-type="pmid">25129165</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antic</surname><given-names>NA</given-names></name><name><surname>Heeley</surname><given-names>E</given-names></name><name><surname>Anderson</surname><given-names>CS</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Neal</surname><given-names>B</given-names></name><name><surname>Grunstein</surname><given-names>R</given-names></name><name><surname>Barbe</surname><given-names>F</given-names></name><name><surname>Lorenzi-Filho</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><etal/></person-group><article-title>The Sleep Apnea cardioVascular Endpoints (SAVE) Trial: Rationale, Ethics, Design, and Progress</article-title><source>Sleep</source><year>2015</year><volume>38</volume><fpage>1247</fpage><lpage>1257</lpage><pub-id pub-id-type="pmid">25669180</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><article-title>Epithelial progenitor cells in lung development, maintenance, repair, and disease</article-title><source>Annu Rev Cell Dev Biol</source><year>2011</year><volume>27</volume><fpage>493</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100109-104040</pub-id><pub-id pub-id-type="pmid">21639799</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>DJ</given-names></name></person-group><article-title>Concise review: current status of stem cells and regenerative medicine in lung biology and diseases</article-title><source>Stem Cells</source><year>2014</year><volume>32</volume><fpage>16</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1002/stem.1506</pub-id><pub-id pub-id-type="pmid">23959715</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajj</surname><given-names>R</given-names></name><name><surname>Baranek</surname><given-names>T</given-names></name><name><surname>Le Naour</surname><given-names>R</given-names></name><name><surname>Lesimple</surname><given-names>P</given-names></name><name><surname>Puchelle</surname><given-names>E</given-names></name><name><surname>Coraux</surname><given-names>C</given-names></name></person-group><article-title>Basal cells of the human adult airway surface epithelium retain transit-amplifying cell properties</article-title><source>Stem Cells</source><year>2007</year><volume>25</volume><fpage>139</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2006-0288</pub-id><pub-id pub-id-type="pmid">17008423</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackett</surname><given-names>TL</given-names></name><name><surname>Shaheen</surname><given-names>F</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name><name><surname>Wadsworth</surname><given-names>S</given-names></name><name><surname>Pechkovsky</surname><given-names>DV</given-names></name><name><surname>Jacoby</surname><given-names>DB</given-names></name><name><surname>Kicic</surname><given-names>A</given-names></name><name><surname>Stick</surname><given-names>SM</given-names></name><name><surname>Knight</surname><given-names>DA</given-names></name></person-group><article-title>Characterization of side population cells from human airway epithelium</article-title><source>Stem Cells</source><year>2008</year><volume>26</volume><fpage>2576</fpage><lpage>2585</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2008-0171</pub-id><pub-id pub-id-type="pmid">18653771</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Onaitis</surname><given-names>MW</given-names></name><name><surname>Rawlins</surname><given-names>EL</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Clark</surname><given-names>CP</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><article-title>Basal cells as stem cells of the mouse trachea and human airway epithelium</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><fpage>12771</fpage><lpage>12775</lpage><pub-id pub-id-type="doi">10.1073/pnas.0906850106</pub-id><pub-id pub-id-type="pmid">19625615</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkauskas</surname><given-names>CE</given-names></name><name><surname>Cronce</surname><given-names>MJ</given-names></name><name><surname>Rackley</surname><given-names>CR</given-names></name><name><surname>Bowie</surname><given-names>EJ</given-names></name><name><surname>Keene</surname><given-names>DR</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><article-title>Type 2 alveolar cells are stem cells in adult lung</article-title><source>J Clin Invest</source><year>2013</year><volume>123</volume><fpage>3025</fpage><lpage>3036</lpage><pub-id pub-id-type="doi">10.1172/JCI68782</pub-id><pub-id pub-id-type="pmid">23921127</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajstura</surname><given-names>J</given-names></name><name><surname>Rota</surname><given-names>M</given-names></name><name><surname>Hall</surname><given-names>SR</given-names></name><name><surname>Hosoda</surname><given-names>T</given-names></name><name><surname>D&#x02019;Amario</surname><given-names>D</given-names></name><name><surname>Sanada</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Og&#x000f3;rek</surname><given-names>B</given-names></name><name><surname>Rondon-Clavo</surname><given-names>C</given-names></name><name><surname>Ferreira-Martins</surname><given-names>J</given-names></name><etal/></person-group><article-title>Evidence for human lung stem cells</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><fpage>1795</fpage><lpage>1806</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1101324</pub-id><pub-id pub-id-type="pmid">21561345</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><collab>Lung stem cells: looking beyond the hype</collab><source>Nat Med</source><year>2011</year><volume>17</volume><fpage>788</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1038/nm0711-788</pub-id><pub-id pub-id-type="pmid">21738157</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oeztuerk-Winder</surname><given-names>F</given-names></name><name><surname>Guinot</surname><given-names>A</given-names></name><name><surname>Ochalek</surname><given-names>A</given-names></name><name><surname>Ventura</surname><given-names>JJ</given-names></name></person-group><article-title>Regulation of human lung alveolar multipotent cells by a novel p38&#x003b1; MAPK/miR-17-92 axis</article-title><source>EMBO J</source><year>2012</year><volume>31</volume><fpage>3431</fpage><lpage>3441</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.192</pub-id><pub-id pub-id-type="pmid">22828869</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lama</surname><given-names>VN</given-names></name><name><surname>Smith</surname><given-names>L</given-names></name><name><surname>Badri</surname><given-names>L</given-names></name><name><surname>Flint</surname><given-names>A</given-names></name><name><surname>Andrei</surname><given-names>AC</given-names></name><name><surname>Murray</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Liao</surname><given-names>H</given-names></name><name><surname>Toews</surname><given-names>GB</given-names></name><name><surname>Krebsbach</surname><given-names>PH</given-names></name><etal/></person-group><article-title>Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts</article-title><source>J Clin Invest</source><year>2007</year><volume>117</volume><fpage>989</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1172/JCI29713</pub-id><pub-id pub-id-type="pmid">17347686</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarvinen</surname><given-names>L</given-names></name><name><surname>Badri</surname><given-names>L</given-names></name><name><surname>Wettlaufer</surname><given-names>S</given-names></name><name><surname>Ohtsuka</surname><given-names>T</given-names></name><name><surname>Standiford</surname><given-names>TJ</given-names></name><name><surname>Toews</surname><given-names>GB</given-names></name><name><surname>Pinsky</surname><given-names>DJ</given-names></name><name><surname>Peters-Golden</surname><given-names>M</given-names></name><name><surname>Lama</surname><given-names>VN</given-names></name></person-group><article-title>Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><fpage>4389</fpage><lpage>4396</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.6.4389</pub-id><pub-id pub-id-type="pmid">18768898</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakob</surname><given-names>M</given-names></name><name><surname>Hemeda</surname><given-names>H</given-names></name><name><surname>Janeschik</surname><given-names>S</given-names></name><name><surname>Bootz</surname><given-names>F</given-names></name><name><surname>Rotter</surname><given-names>N</given-names></name><name><surname>Lang</surname><given-names>S</given-names></name><name><surname>Brandau</surname><given-names>S</given-names></name></person-group><article-title>Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells</article-title><source>Stem Cells Dev</source><year>2010</year><volume>19</volume><fpage>635</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1089/scd.2009.0245</pub-id><pub-id pub-id-type="pmid">19761404</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozyk</surname><given-names>PD</given-names></name><name><surname>Popova</surname><given-names>AP</given-names></name><name><surname>Bentley</surname><given-names>JK</given-names></name><name><surname>Goldsmith</surname><given-names>AM</given-names></name><name><surname>Linn</surname><given-names>MJ</given-names></name><name><surname>Weiss</surname><given-names>DJ</given-names></name><name><surname>Hershenson</surname><given-names>MB</given-names></name></person-group><article-title>Mesenchymal stromal cells from neonatal tracheal aspirates demonstrate a pattern of lung-specific gene expression</article-title><source>Stem Cells Dev</source><year>2011</year><volume>20</volume><fpage>1995</fpage><lpage>2007</lpage><pub-id pub-id-type="doi">10.1089/scd.2010.0494</pub-id><pub-id pub-id-type="pmid">21341990</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><collab>Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E</collab><article-title>Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement</article-title><source>Cytotherapy</source><year>2006</year><volume>8</volume><fpage>315</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1080/14653240600855905</pub-id><pub-id pub-id-type="pmid">16923606</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Schuetz</surname><given-names>JD</given-names></name><name><surname>Bunting</surname><given-names>KD</given-names></name><name><surname>Colapietro</surname><given-names>AM</given-names></name><name><surname>Sampath</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>JJ</given-names></name><name><surname>Lagutina</surname><given-names>I</given-names></name><name><surname>Grosveld</surname><given-names>GC</given-names></name><name><surname>Osawa</surname><given-names>M</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name><etal/></person-group><article-title>The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><fpage>1028</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1038/nm0901-1028</pub-id><pub-id pub-id-type="pmid">11533706</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popova</surname><given-names>AP</given-names></name><name><surname>Bozyk</surname><given-names>PD</given-names></name><name><surname>Bentley</surname><given-names>JK</given-names></name><name><surname>Linn</surname><given-names>MJ</given-names></name><name><surname>Goldsmith</surname><given-names>AM</given-names></name><name><surname>Schumacher</surname><given-names>RE</given-names></name><name><surname>Weiner</surname><given-names>GM</given-names></name><name><surname>Filbrun</surname><given-names>AG</given-names></name><name><surname>Hershenson</surname><given-names>MB</given-names></name></person-group><article-title>Isolation of tracheal aspirate mesenchymal stromal cells predicts bronchopulmonary dysplasia</article-title><source>Pediatrics</source><year>2010</year><volume>126</volume><fpage>e1127</fpage><lpage>e1133</lpage><pub-id pub-id-type="doi">10.1542/peds.2009-3445</pub-id><pub-id pub-id-type="pmid">20937656</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crisan</surname><given-names>M</given-names></name><name><surname>Yap</surname><given-names>S</given-names></name><name><surname>Casteilla</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>CW</given-names></name><name><surname>Corselli</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>TS</given-names></name><name><surname>Andriolo</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group><article-title>A perivascular origin for mesenchymal stem cells in multiple human organs</article-title><source>Cell Stem Cell</source><year>2008</year><volume>3</volume><fpage>301</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2008.07.003</pub-id><pub-id pub-id-type="pmid">18786417</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolandsson</surname><given-names>S</given-names></name><name><surname>Andersson Sj&#x000f6;land</surname><given-names>A</given-names></name><name><surname>Brune</surname><given-names>JC</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Kassem</surname><given-names>M</given-names></name><name><surname>Mertens</surname><given-names>F</given-names></name><name><surname>Westergren</surname><given-names>A</given-names></name><name><surname>Eriksson</surname><given-names>L</given-names></name><name><surname>Hansson</surname><given-names>L</given-names></name><name><surname>Skog</surname><given-names>I</given-names></name><etal/></person-group><article-title>Primary mesenchymal stem cells in human transplanted lungs are CD90/CD105 perivascularly located tissue-resident cells</article-title><source>BMJ Open Respir Res</source><year>2014</year><volume>1</volume><fpage>e000027</fpage><pub-id pub-id-type="doi">10.1136/bmjresp-2014-000027</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva Meirelles</surname><given-names>L</given-names></name><name><surname>Caplan</surname><given-names>AI</given-names></name><name><surname>Nardi</surname><given-names>NB</given-names></name></person-group><article-title>In search of the in vivo identity of mesenchymal stem cells</article-title><source>Stem Cells</source><year>2008</year><volume>26</volume><fpage>2287</fpage><lpage>2299</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2007-1122</pub-id><pub-id pub-id-type="pmid">18566331</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva Meirelles</surname><given-names>L</given-names></name><name><surname>Chagastelles</surname><given-names>PC</given-names></name><name><surname>Nardi</surname><given-names>NB</given-names></name></person-group><article-title>Mesenchymal stem cells reside in virtually all post-natal organs and tissues</article-title><source>J Cell Sci</source><year>2006</year><volume>119</volume><fpage>2204</fpage><lpage>2213</lpage><pub-id pub-id-type="doi">10.1242/jcs.02932</pub-id><pub-id pub-id-type="pmid">16684817</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bluguermann</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Petrigliano</surname><given-names>F</given-names></name><name><surname>McAllister</surname><given-names>D</given-names></name><name><surname>Miriuka</surname><given-names>S</given-names></name><name><surname>Evseenko</surname><given-names>DA</given-names></name></person-group><article-title>Novel aspects of parenchymal-mesenchymal interactions: from cell types to molecules and beyond</article-title><source>Cell Biochem Funct</source><year>2013</year><volume>31</volume><fpage>271</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1002/cbf.2950</pub-id><pub-id pub-id-type="pmid">23315627</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Murohara</surname><given-names>T</given-names></name><name><surname>Sullivan</surname><given-names>A</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><name><surname>van der Zee</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Witzenbichler</surname><given-names>B</given-names></name><name><surname>Schatteman</surname><given-names>G</given-names></name><name><surname>Isner</surname><given-names>JM</given-names></name></person-group><article-title>Isolation of putative progenitor endothelial cells for angiogenesis</article-title><source>Science</source><year>1997</year><volume>275</volume><fpage>964</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1126/science.275.5302.964</pub-id><pub-id pub-id-type="pmid">9020076</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Masuda</surname><given-names>H</given-names></name><name><surname>Kalka</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Iwaguro</surname><given-names>H</given-names></name><name><surname>Inai</surname><given-names>Y</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><name><surname>Isner</surname><given-names>JM</given-names></name></person-group><article-title>VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells</article-title><source>EMBO J</source><year>1999</year><volume>18</volume><fpage>3964</fpage><lpage>3972</lpage><pub-id pub-id-type="doi">10.1093/emboj/18.14.3964</pub-id><pub-id pub-id-type="pmid">10406801</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Kalka</surname><given-names>C</given-names></name><name><surname>Masuda</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><name><surname>Kearney</surname><given-names>M</given-names></name><name><surname>Magner</surname><given-names>M</given-names></name><name><surname>Isner</surname><given-names>JM</given-names></name><name><surname>Asahara</surname><given-names>T</given-names></name></person-group><article-title>Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization</article-title><source>Nat Med</source><year>1999</year><volume>5</volume><fpage>434</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1038/7434</pub-id><pub-id pub-id-type="pmid">10202935</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingram</surname><given-names>DA</given-names></name><name><surname>Mead</surname><given-names>LE</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Meade</surname><given-names>V</given-names></name><name><surname>Fenoglio</surname><given-names>A</given-names></name><name><surname>Mortell</surname><given-names>K</given-names></name><name><surname>Pollok</surname><given-names>K</given-names></name><name><surname>Ferkowicz</surname><given-names>MJ</given-names></name><name><surname>Gilley</surname><given-names>D</given-names></name><name><surname>Yoder</surname><given-names>MC</given-names></name></person-group><article-title>Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood</article-title><source>Blood</source><year>2004</year><volume>104</volume><fpage>2752</fpage><lpage>2760</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-04-1396</pub-id><pub-id pub-id-type="pmid">15226175</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khakoo</surname><given-names>AY</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name></person-group><article-title>Endothelial progenitor cells</article-title><source>Annu Rev Med</source><year>2005</year><volume>56</volume><fpage>79</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1146/annurev.med.56.090203.104149</pub-id><pub-id pub-id-type="pmid">15660503</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>DF</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>King</surname><given-names>JA</given-names></name><name><surname>ElZarrad</surname><given-names>MK</given-names></name><name><surname>Yoder</surname><given-names>MC</given-names></name><name><surname>Stevens</surname><given-names>T</given-names></name></person-group><article-title>Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2008</year><volume>294</volume><fpage>L419</fpage><lpage>L430</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00314.2007</pub-id><pub-id pub-id-type="pmid">18065657</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schniedermann</surname><given-names>J</given-names></name><name><surname>Rennecke</surname><given-names>M</given-names></name><name><surname>Buttler</surname><given-names>K</given-names></name><name><surname>Richter</surname><given-names>G</given-names></name><name><surname>St&#x000e4;dtler</surname><given-names>AM</given-names></name><name><surname>Norgall</surname><given-names>S</given-names></name><name><surname>Badar</surname><given-names>M</given-names></name><name><surname>Barleon</surname><given-names>B</given-names></name><name><surname>May</surname><given-names>T</given-names></name><name><surname>Wilting</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mouse lung contains endothelial progenitors with high capacity to form blood and lymphatic vessels</article-title><source>BMC Cell Biol</source><year>2010</year><volume>11</volume><fpage>50</fpage><pub-id pub-id-type="doi">10.1186/1471-2121-11-50</pub-id><pub-id pub-id-type="pmid">20594323</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basile</surname><given-names>DP</given-names></name><name><surname>Yoder</surname><given-names>MC</given-names></name></person-group><article-title>Circulating and tissue resident endothelial progenitor cells</article-title><source>J Cell Physiol</source><year>2014</year><volume>229</volume><fpage>10</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/jcp.24423</pub-id><pub-id pub-id-type="pmid">23794280</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almendros</surname><given-names>I</given-names></name><name><surname>Carreras</surname><given-names>A</given-names></name><name><surname>Montserrat</surname><given-names>JM</given-names></name><name><surname>Gozal</surname><given-names>D</given-names></name><name><surname>Navajas</surname><given-names>D</given-names></name><name><surname>Farre</surname><given-names>R</given-names></name></person-group><article-title>Potential role of adult stem cells in obstructive sleep apnea</article-title><source>Front Neurol</source><year>2012</year><volume>3</volume><fpage>112</fpage><pub-id pub-id-type="doi">10.3389/fneur.2012.00112</pub-id><pub-id pub-id-type="pmid">22807922</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>H</given-names></name><name><surname>Rovira</surname><given-names>II</given-names></name><name><surname>Bloom</surname><given-names>ML</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Ferrans</surname><given-names>VJ</given-names></name><name><surname>Quyyumi</surname><given-names>AA</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name></person-group><article-title>Endothelial progenitor cells as putative targets for angiostatin</article-title><source>Cancer Res</source><year>1999</year><volume>59</volume><fpage>5875</fpage><lpage>5877</lpage><pub-id pub-id-type="pmid">10606226</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>JM</given-names></name><name><surname>Zalos</surname><given-names>G</given-names></name><name><surname>Halcox</surname><given-names>JP</given-names></name><name><surname>Schenke</surname><given-names>WH</given-names></name><name><surname>Waclawiw</surname><given-names>MA</given-names></name><name><surname>Quyyumi</surname><given-names>AA</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name></person-group><article-title>Circulating endothelial progenitor cells, vascular function, and cardiovascular risk</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>593</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa022287</pub-id><pub-id pub-id-type="pmid">12584367</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohde</surname><given-names>E</given-names></name><name><surname>Malischnik</surname><given-names>C</given-names></name><name><surname>Thaler</surname><given-names>D</given-names></name><name><surname>Maierhofer</surname><given-names>T</given-names></name><name><surname>Linkesch</surname><given-names>W</given-names></name><name><surname>Lanzer</surname><given-names>G</given-names></name><name><surname>Guelly</surname><given-names>C</given-names></name><name><surname>Strunk</surname><given-names>D</given-names></name></person-group><article-title>Blood monocytes mimic endothelial progenitor cells</article-title><source>Stem Cells</source><year>2006</year><volume>24</volume><fpage>357</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2005-0072</pub-id><pub-id pub-id-type="pmid">16141361</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohde</surname><given-names>E</given-names></name><name><surname>Bartmann</surname><given-names>C</given-names></name><name><surname>Schallmoser</surname><given-names>K</given-names></name><name><surname>Reinisch</surname><given-names>A</given-names></name><name><surname>Lanzer</surname><given-names>G</given-names></name><name><surname>Linkesch</surname><given-names>W</given-names></name><name><surname>Guelly</surname><given-names>C</given-names></name><name><surname>Strunk</surname><given-names>D</given-names></name></person-group><article-title>Immune cells mimic the morphology of endothelial progenitor colonies in vitro</article-title><source>Stem Cells</source><year>2007</year><volume>25</volume><fpage>1746</fpage><lpage>1752</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2006-0833</pub-id><pub-id pub-id-type="pmid">17395771</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoder</surname><given-names>MC</given-names></name><name><surname>Mead</surname><given-names>LE</given-names></name><name><surname>Prater</surname><given-names>D</given-names></name><name><surname>Krier</surname><given-names>TR</given-names></name><name><surname>Mroueh</surname><given-names>KN</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Krasich</surname><given-names>R</given-names></name><name><surname>Temm</surname><given-names>CJ</given-names></name><name><surname>Prchal</surname><given-names>JT</given-names></name><name><surname>Ingram</surname><given-names>DA</given-names></name></person-group><article-title>Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals</article-title><source>Blood</source><year>2007</year><volume>109</volume><fpage>1801</fpage><lpage>1809</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-08-043471</pub-id><pub-id pub-id-type="pmid">17053059</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>N</given-names></name><name><surname>Junk</surname><given-names>S</given-names></name><name><surname>Laufs</surname><given-names>U</given-names></name><name><surname>Link</surname><given-names>A</given-names></name><name><surname>Walenta</surname><given-names>K</given-names></name><name><surname>Bohm</surname><given-names>M</given-names></name><name><surname>Nickenig</surname><given-names>G</given-names></name></person-group><article-title>Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury</article-title><source>Circ Res</source><year>2003</year><volume>93</volume><fpage>e17</fpage><lpage>e24</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000083812.30141.74</pub-id><pub-id pub-id-type="pmid">12829619</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hristov</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>C</given-names></name></person-group><article-title>Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance</article-title><source>J Cell Mol Med</source><year>2004</year><volume>8</volume><fpage>498</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1111/j.1582-4934.2004.tb00474.x</pub-id><pub-id pub-id-type="pmid">15601578</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname><given-names>M</given-names></name><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Hamada</surname><given-names>H</given-names></name><name><surname>Ohneda</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Shibuya</surname><given-names>M</given-names></name><name><surname>Yoshikawa</surname><given-names>H</given-names></name><name><surname>Ohneda</surname><given-names>O</given-names></name></person-group><article-title>Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood</article-title><source>Blood</source><year>2007</year><volume>110</volume><fpage>151</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-10-047092</pub-id><pub-id pub-id-type="pmid">17379743</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>J</given-names></name><name><surname>Yoon</surname><given-names>CH</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Kang</surname><given-names>HJ</given-names></name><name><surname>Hwang</surname><given-names>KK</given-names></name><name><surname>Oh</surname><given-names>BH</given-names></name><name><surname>Lee</surname><given-names>MM</given-names></name><name><surname>Park</surname><given-names>YB</given-names></name></person-group><article-title>Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><fpage>288</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000114236.77009.06</pub-id><pub-id pub-id-type="pmid">14699017</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sieveking</surname><given-names>DP</given-names></name><name><surname>Buckle</surname><given-names>A</given-names></name><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Ng</surname><given-names>MK</given-names></name></person-group><article-title>Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay</article-title><source>J Am Coll Cardiol</source><year>2008</year><volume>51</volume><fpage>660</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2007.09.059</pub-id><pub-id pub-id-type="pmid">18261686</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Masuda</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Kalka</surname><given-names>C</given-names></name><name><surname>Pastore</surname><given-names>C</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><name><surname>Kearne</surname><given-names>M</given-names></name><name><surname>Magner</surname><given-names>M</given-names></name><name><surname>Isner</surname><given-names>JM</given-names></name></person-group><article-title>Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization</article-title><source>Circ Res</source><year>1999</year><volume>85</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1161/01.RES.85.3.221</pub-id><pub-id pub-id-type="pmid">10436164</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgescu</surname><given-names>A</given-names></name></person-group><article-title>Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy</article-title><source>World J Diabetes</source><year>2011</year><volume>2</volume><fpage>92</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.4239/wjd.v2.i6.92</pub-id><pub-id pub-id-type="pmid">21860692</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaji</surname><given-names>S</given-names></name><name><surname>King</surname><given-names>A</given-names></name><name><surname>Crombleholme</surname><given-names>TM</given-names></name><name><surname>Keswani</surname><given-names>SG</given-names></name></person-group><article-title>The Role of Endothelial Progenitor Cells in Postnatal Vasculogenesis: Implications for Therapeutic Neovascularization and Wound Healing</article-title><source>Adv Wound Care (New Rochelle)</source><year>2013</year><volume>2</volume><fpage>283</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1089/wound.2012.0398</pub-id><pub-id pub-id-type="pmid">24527350</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PS</given-names></name><name><surname>Poh</surname><given-names>KK</given-names></name></person-group><article-title>Endothelial progenitor cells in cardiovascular diseases</article-title><source>World J Stem Cells</source><year>2014</year><volume>6</volume><fpage>355</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.4252/wjsc.v6.i3.355</pub-id><pub-id pub-id-type="pmid">25126384</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moccia</surname><given-names>F</given-names></name><name><surname>Zuccolo</surname><given-names>E</given-names></name><name><surname>Poletto</surname><given-names>V</given-names></name><name><surname>Cinelli</surname><given-names>M</given-names></name><name><surname>Bonetti</surname><given-names>E</given-names></name><name><surname>Guerra</surname><given-names>G</given-names></name><name><surname>Rosti</surname><given-names>V</given-names></name></person-group><article-title>Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapy</article-title><source>Tumour Biol</source><year>2015</year><volume>36</volume><fpage>6603</fpage><lpage>6614</lpage><pub-id pub-id-type="doi">10.1007/s13277-015-3823-2</pub-id><pub-id pub-id-type="pmid">26232913</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>J</given-names></name><name><surname>Kusano</surname><given-names>KF</given-names></name><name><surname>Masuo</surname><given-names>O</given-names></name><name><surname>Kawamoto</surname><given-names>A</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><name><surname>Murasawa</surname><given-names>S</given-names></name><name><surname>Bosch-Marce</surname><given-names>M</given-names></name><name><surname>Masuda</surname><given-names>H</given-names></name><name><surname>Losordo</surname><given-names>DW</given-names></name><name><surname>Isner</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization</article-title><source>Circulation</source><year>2003</year><volume>107</volume><fpage>1322</fpage><lpage>1328</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000055313.77510.22</pub-id><pub-id pub-id-type="pmid">12628955</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amano</surname><given-names>K</given-names></name><name><surname>Okigaki</surname><given-names>M</given-names></name><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Fujiyama</surname><given-names>S</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Kosaki</surname><given-names>A</given-names></name><name><surname>Iwasaka</surname><given-names>T</given-names></name><name><surname>Matsubara</surname><given-names>H</given-names></name></person-group><article-title>Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice</article-title><source>J Mol Cell Cardiol</source><year>2004</year><volume>36</volume><fpage>469</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2004.01.006</pub-id><pub-id pub-id-type="pmid">15081307</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceradini</surname><given-names>DJ</given-names></name><name><surname>Kulkarni</surname><given-names>AR</given-names></name><name><surname>Callaghan</surname><given-names>MJ</given-names></name><name><surname>Tepper</surname><given-names>OM</given-names></name><name><surname>Bastidas</surname><given-names>N</given-names></name><name><surname>Kleinman</surname><given-names>ME</given-names></name><name><surname>Capla</surname><given-names>JM</given-names></name><name><surname>Galiano</surname><given-names>RD</given-names></name><name><surname>Levine</surname><given-names>JP</given-names></name><name><surname>Gurtner</surname><given-names>GC</given-names></name></person-group><article-title>Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>858</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1038/nm1075</pub-id><pub-id pub-id-type="pmid">15235597</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smart</surname><given-names>N</given-names></name><name><surname>Riley</surname><given-names>PR</given-names></name></person-group><article-title>The stem cell movement</article-title><source>Circ Res</source><year>2008</year><volume>102</volume><fpage>1155</fpage><lpage>1168</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.175158</pub-id><pub-id pub-id-type="pmid">18497316</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tousoulis</surname><given-names>D</given-names></name><name><surname>Andreou</surname><given-names>I</given-names></name><name><surname>Antoniades</surname><given-names>C</given-names></name><name><surname>Tentolouris</surname><given-names>C</given-names></name><name><surname>Stefanadis</surname><given-names>C</given-names></name></person-group><article-title>Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases</article-title><source>Atherosclerosis</source><year>2008</year><volume>201</volume><fpage>236</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2008.05.034</pub-id><pub-id pub-id-type="pmid">18599065</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadeem</surname><given-names>R</given-names></name><name><surname>Molnar</surname><given-names>J</given-names></name><name><surname>Madbouly</surname><given-names>EM</given-names></name><name><surname>Nida</surname><given-names>M</given-names></name><name><surname>Aggarwal</surname><given-names>S</given-names></name><name><surname>Sajid</surname><given-names>H</given-names></name><name><surname>Naseem</surname><given-names>J</given-names></name><name><surname>Loomba</surname><given-names>R</given-names></name></person-group><article-title>Serum inflammatory markers in obstructive sleep apnea: a meta-analysis</article-title><source>J Clin Sleep Med</source><year>2013</year><volume>9</volume><fpage>1003</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.5664/jcsm.3070</pub-id><pub-id pub-id-type="pmid">24127144</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca Canto</surname><given-names>G</given-names></name><name><surname>Pach&#x000ea;co-Pereira</surname><given-names>C</given-names></name><name><surname>Aydinoz</surname><given-names>S</given-names></name><name><surname>Major</surname><given-names>PW</given-names></name><name><surname>Flores-Mir</surname><given-names>C</given-names></name><name><surname>Gozal</surname><given-names>D</given-names></name></person-group><article-title>Biomarkers associated with obstructive sleep apnea and morbidities: a scoping review</article-title><source>Sleep Med</source><year>2015</year><volume>16</volume><fpage>347</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1016/j.sleep.2014.12.007</pub-id><pub-id pub-id-type="pmid">25747333</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name></person-group><article-title>Impact of Obstructive Sleep Apnea Syndrome on Endothelial Function, Arterial Stiffening, and Serum Inflammatory Markers: An Updated Meta-analysis and Metaregression of 18 Studies</article-title><source>J Am Heart Assoc</source><year>2015</year><volume>4</volume><fpage>pii: e002454</fpage><pub-id pub-id-type="doi">10.1161/JAHA.115.002454</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><article-title>Obstructive sleep apnea and endothelial progenitor cells</article-title><source>Patient Prefer Adherence</source><year>2013</year><volume>7</volume><fpage>1077</fpage><lpage>1090</lpage><pub-id pub-id-type="doi">10.2147/PPA.S51562</pub-id><pub-id pub-id-type="pmid">24204127</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Pe&#x000f1;a</surname><given-names>M</given-names></name><name><surname>Barcel&#x000f3;</surname><given-names>A</given-names></name><name><surname>Barbe</surname><given-names>F</given-names></name><name><surname>Pi&#x000e9;rola</surname><given-names>J</given-names></name><name><surname>Pons</surname><given-names>J</given-names></name><name><surname>Rimbau</surname><given-names>E</given-names></name><name><surname>Ayll&#x000f3;n</surname><given-names>O</given-names></name><name><surname>Agust&#x000ed;</surname><given-names>AG</given-names></name></person-group><article-title>Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome</article-title><source>Respiration</source><year>2008</year><volume>76</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1159/000109643</pub-id><pub-id pub-id-type="pmid">17921670</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jelic</surname><given-names>S</given-names></name><name><surname>Padeletti</surname><given-names>M</given-names></name><name><surname>Kawut</surname><given-names>SM</given-names></name><name><surname>Higgins</surname><given-names>C</given-names></name><name><surname>Canfield</surname><given-names>SM</given-names></name><name><surname>Onat</surname><given-names>D</given-names></name><name><surname>Colombo</surname><given-names>PC</given-names></name><name><surname>Basner</surname><given-names>RC</given-names></name><name><surname>Factor</surname><given-names>P</given-names></name><name><surname>LeJemtel</surname><given-names>TH</given-names></name></person-group><article-title>Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea</article-title><source>Circulation</source><year>2008</year><volume>117</volume><fpage>2270</fpage><lpage>2278</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.741512</pub-id><pub-id pub-id-type="pmid">18413499</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jelic</surname><given-names>S</given-names></name><name><surname>Lederer</surname><given-names>DJ</given-names></name><name><surname>Adams</surname><given-names>T</given-names></name><name><surname>Padeletti</surname><given-names>M</given-names></name><name><surname>Colombo</surname><given-names>PC</given-names></name><name><surname>Factor</surname><given-names>P</given-names></name><name><surname>Le Jemtel</surname><given-names>TH</given-names></name></person-group><article-title>Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea</article-title><source>Vasc Health Risk Manag</source><year>2009</year><volume>5</volume><fpage>909</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.2147/VHRM.S8123</pub-id><pub-id pub-id-type="pmid">19997572</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murri</surname><given-names>M</given-names></name><name><surname>Garc&#x000ed;a-Delgado</surname><given-names>R</given-names></name><name><surname>Alc&#x000e1;zar-Ram&#x000ed;rez</surname><given-names>J</given-names></name><name><surname>Fern&#x000e1;ndez-Ramos</surname><given-names>A</given-names></name><name><surname>Alcaide</surname><given-names>J</given-names></name><name><surname>Cardona</surname><given-names>F</given-names></name><name><surname>Tinahones</surname><given-names>FJ</given-names></name></person-group><article-title>Effect of CPAP on oxidative stress and circulating progenitor cell levels in sleep patients with apnea-hypopnea syndrome</article-title><source>Respir Care</source><year>2011</year><volume>56</volume><fpage>1830</fpage><lpage>1836</lpage><pub-id pub-id-type="doi">10.4187/respcare.01081</pub-id><pub-id pub-id-type="pmid">21605479</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheirandish-Gozal</surname><given-names>L</given-names></name><name><surname>Bhattacharjee</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Clair</surname><given-names>HB</given-names></name><name><surname>Gozal</surname><given-names>D</given-names></name></person-group><article-title>Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>182</volume><fpage>92</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1164/rccm.200912-1845OC</pub-id><pub-id pub-id-type="pmid">20203242</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>K</given-names></name><name><surname>Stanchina</surname><given-names>M</given-names></name><name><surname>Kouttab</surname><given-names>N</given-names></name><name><surname>Harrington</surname><given-names>EO</given-names></name><name><surname>Rounds</surname><given-names>S</given-names></name></person-group><article-title>Circulating endothelial cells and endothelial progenitor cells in obstructive sleep apnea</article-title><source>Lung</source><year>2008</year><volume>186</volume><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1007/s00408-008-9073-y</pub-id><pub-id pub-id-type="pmid">18401642</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>CH</given-names></name><name><surname>Jung</surname><given-names>KH</given-names></name><name><surname>Chu</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Ji</surname><given-names>KH</given-names></name><name><surname>Park</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>HC</given-names></name><name><surname>Lee</surname><given-names>ST</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Roh</surname><given-names>JK</given-names></name></person-group><article-title>Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea</article-title><source>J Clin Neurol</source><year>2010</year><volume>6</volume><fpage>89</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.3988/jcn.2010.6.2.89</pub-id><pub-id pub-id-type="pmid">20607048</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>PJ</given-names></name><name><surname>Hoyos</surname><given-names>CM</given-names></name><name><surname>Celermajer</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>PY</given-names></name><name><surname>Ng</surname><given-names>MK</given-names></name></person-group><article-title>Effects of continuous positive airway pressure on endothelial function and circulating progenitor cells in obstructive sleep apnoea: a randomised sham-controlled study</article-title><source>Int J Cardiol</source><year>2013</year><volume>168</volume><fpage>2042</fpage><lpage>2048</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2013.01.166</pub-id><pub-id pub-id-type="pmid">23453448</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kizawa</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Sakurai</surname><given-names>S</given-names></name><name><surname>Yamauchi</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name></person-group><article-title>Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea</article-title><source>Eur Respir J</source><year>2009</year><volume>34</volume><fpage>1390</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1183/09031936.00009709</pub-id><pub-id pub-id-type="pmid">19574336</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lui</surname><given-names>MM</given-names></name><name><surname>Tse</surname><given-names>HF</given-names></name><name><surname>Mak</surname><given-names>JC</given-names></name><name><surname>Lam</surname><given-names>JC</given-names></name><name><surname>Lam</surname><given-names>DC</given-names></name><name><surname>Tan</surname><given-names>KC</given-names></name><name><surname>Ip</surname><given-names>MS</given-names></name></person-group><article-title>Altered profile of circulating endothelial progenitor cells in obstructive sleep apnea</article-title><source>Sleep Breath</source><year>2013</year><volume>17</volume><fpage>937</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1007/s11325-012-0781-4</pub-id><pub-id pub-id-type="pmid">23179139</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>KT</given-names></name><name><surname>Liu</surname><given-names>CC</given-names></name><name><surname>Hsu</surname><given-names>HS</given-names></name><name><surname>Chang</surname><given-names>SC</given-names></name><name><surname>Chen</surname><given-names>YM</given-names></name><name><surname>Perng</surname><given-names>DW</given-names></name><name><surname>Hsu</surname><given-names>YT</given-names></name><name><surname>Lee</surname><given-names>YC</given-names></name><name><surname>Hung</surname><given-names>SC</given-names></name></person-group><article-title>Nocturnal stem cell mobilization in patients with obstructive sleep apnoea: a pilot study</article-title><source>Eur J Clin Invest</source><year>2014</year><volume>44</volume><fpage>1189</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1111/eci.12353</pub-id><pub-id pub-id-type="pmid">25331065</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deleanu</surname><given-names>OC</given-names></name><name><surname>M&#x00103;l&#x00103;u&#x00163;</surname><given-names>AE</given-names></name><name><surname>Nebunoiu</surname><given-names>AM</given-names></name><name><surname>Micheu</surname><given-names>MM</given-names></name><name><surname>Mih&#x00103;l&#x00163;an</surname><given-names>FD</given-names></name></person-group><article-title>Obstructive sleep apnea syndrome and arterial hypertension--a complicated relationship? The role of controlling blood pressure values in patients with OSAS</article-title><source>Pneumologia</source><year>2014</year><volume>63</volume><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">24800594</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzi</surname><given-names>CF</given-names></name><name><surname>Ferraz</surname><given-names>MB</given-names></name><name><surname>Poyares</surname><given-names>D</given-names></name><name><surname>Tufik</surname><given-names>S</given-names></name></person-group><article-title>Quality-adjusted life-years gain and health status in patients with OSAS after one year of continuous positive airway pressure use</article-title><source>Sleep</source><year>2014</year><volume>37</volume><fpage>1963</fpage><lpage>1968</lpage><pub-id pub-id-type="doi">10.5665/sleep.4250</pub-id><pub-id pub-id-type="pmid">25325505</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimi</surname><given-names>M</given-names></name><name><surname>Hedner</surname><given-names>J</given-names></name><name><surname>H&#x000e4;bel</surname><given-names>H</given-names></name><name><surname>Nerman</surname><given-names>O</given-names></name><name><surname>Grote</surname><given-names>L</given-names></name></person-group><article-title>Sleep apnea-related risk of motor vehicle accidents is reduced by continuous positive airway pressure: Swedish Traffic Accident Registry data</article-title><source>Sleep</source><year>2015</year><volume>38</volume><fpage>341</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.5665/sleep.4486</pub-id><pub-id pub-id-type="pmid">25325460</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauters</surname><given-names>F</given-names></name><name><surname>Rietzschel</surname><given-names>ER</given-names></name><name><surname>Hertegonne</surname><given-names>KB</given-names></name><name><surname>Chirinos</surname><given-names>JA</given-names></name></person-group><article-title>The Link Between Obstructive Sleep Apnea and Cardiovascular Disease</article-title><source>Curr Atheroscler Rep</source><year>2016</year><volume>18</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1007/s11883-015-0556-z</pub-id><pub-id pub-id-type="pmid">26710793</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donovan</surname><given-names>LM</given-names></name><name><surname>Boeder</surname><given-names>S</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name></person-group><article-title>New developments in the use of positive airway pressure for obstructive sleep apnea</article-title><source>J Thorac Dis</source><year>2015</year><volume>7</volume><fpage>1323</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.3978/j.issn.2072-1439.2015.07.30</pub-id><pub-id pub-id-type="pmid">26380760</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>AY</given-names></name><name><surname>Ip</surname><given-names>MS</given-names></name><name><surname>Lam</surname><given-names>JC</given-names></name><name><surname>Weaver</surname><given-names>TE</given-names></name><name><surname>Fong</surname><given-names>DY</given-names></name></person-group><article-title>A pathway underlying the impact of CPAP adherence on intimate relationship with bed partner in men with obstructive sleep apnea</article-title><source>Sleep Breath</source><year>2016</year><volume>20</volume><fpage>543</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1007/s11325-015-1235-6</pub-id><pub-id pub-id-type="pmid">26265560</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>JP</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Weng</surname><given-names>J</given-names></name><name><surname>Aloia</surname><given-names>MS</given-names></name><name><surname>Toth</surname><given-names>C</given-names></name><name><surname>Morrical</surname><given-names>MG</given-names></name><name><surname>Gleason</surname><given-names>KJ</given-names></name><name><surname>Rueschman</surname><given-names>M</given-names></name><name><surname>Dorsey</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Motivational Enhancement for Increasing Adherence to CPAP: A Randomized Controlled Trial</article-title><source>Chest</source><year>2016</year><volume>150</volume><fpage>337</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.chest.2016.03.019</pub-id><pub-id pub-id-type="pmid">27018174</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudley</surname><given-names>KA</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name></person-group><article-title>Disparities and genetic risk factors in obstructive sleep apnea</article-title><source>Sleep Med</source><year>2016</year><volume>18</volume><fpage>96</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.sleep.2015.01.015</pub-id><pub-id pub-id-type="pmid">26428843</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>SW</given-names></name><name><surname>Sebasti&#x000e3;o</surname><given-names>Y</given-names></name><name><surname>Rosas</surname><given-names>J</given-names></name><name><surname>Iannacone</surname><given-names>MR</given-names></name><name><surname>Foulis</surname><given-names>PR</given-names></name><name><surname>Anderson</surname><given-names>WM</given-names></name></person-group><article-title>Racial disparity in adherence to positive airway pressure among US veterans</article-title><source>Sleep Breath</source><year>2016</year><volume>20</volume><fpage>947</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1007/s11325-016-1316-1</pub-id><pub-id pub-id-type="pmid">26810493</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>TE</given-names></name><name><surname>Grunstein</surname><given-names>RR</given-names></name></person-group><article-title>Adherence to continuous positive airway pressure therapy: the challenge to effective treatment</article-title><source>Proc Am Thorac Soc</source><year>2008</year><volume>5</volume><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1513/pats.200708-119MG</pub-id><pub-id pub-id-type="pmid">18250209</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai-Coetzer</surname><given-names>CL</given-names></name><name><surname>Luo</surname><given-names>YM</given-names></name><name><surname>Antic</surname><given-names>NA</given-names></name><name><surname>Zhang</surname><given-names>XL</given-names></name><name><surname>Chen</surname><given-names>BY</given-names></name><name><surname>He</surname><given-names>QY</given-names></name><name><surname>Heeley</surname><given-names>E</given-names></name><name><surname>Huang</surname><given-names>SG</given-names></name><name><surname>Anderson</surname><given-names>C</given-names></name><name><surname>Zhong</surname><given-names>NS</given-names></name><etal/></person-group><article-title>Predictors of long-term adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea and cardiovascular disease in the SAVE study</article-title><source>Sleep</source><year>2013</year><volume>36</volume><fpage>1929</fpage><lpage>1937</lpage><pub-id pub-id-type="doi">10.5665/sleep.3232</pub-id><pub-id pub-id-type="pmid">24293768</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>MC</given-names></name><name><surname>Huang</surname><given-names>YC</given-names></name><name><surname>Lan</surname><given-names>CC</given-names></name><name><surname>Wu</surname><given-names>YK</given-names></name><name><surname>Huang</surname><given-names>KF</given-names></name></person-group><article-title>Beneficial Effects of Long-Term CPAP Treatment on Sleep Quality and Blood Pressure in Adherent Subjects With Obstructive Sleep Apnea</article-title><source>Respir Care</source><year>2015</year><volume>60</volume><fpage>1810</fpage><lpage>1818</lpage><pub-id pub-id-type="doi">10.4187/respcare.04199</pub-id><pub-id pub-id-type="pmid">26396261</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reeves-Hoche</surname><given-names>MK</given-names></name><name><surname>Meck</surname><given-names>R</given-names></name><name><surname>Zwillich</surname><given-names>CW</given-names></name></person-group><article-title>Nasal CPAP: an objective evaluation of patient compliance</article-title><source>Am J Respir Crit Care Med</source><year>1994</year><volume>149</volume><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.149.1.8111574</pub-id><pub-id pub-id-type="pmid">8111574</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engleman</surname><given-names>HM</given-names></name><name><surname>Martin</surname><given-names>SE</given-names></name><name><surname>Douglas</surname><given-names>NJ</given-names></name></person-group><article-title>Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome</article-title><source>Thorax</source><year>1994</year><volume>49</volume><fpage>263</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1136/thx.49.3.263</pub-id><pub-id pub-id-type="pmid">8202884</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>TE</given-names></name><name><surname>Maislin</surname><given-names>G</given-names></name><name><surname>Dinges</surname><given-names>DF</given-names></name><name><surname>Bloxham</surname><given-names>T</given-names></name><name><surname>George</surname><given-names>CF</given-names></name><name><surname>Greenberg</surname><given-names>H</given-names></name><name><surname>Kader</surname><given-names>G</given-names></name><name><surname>Mahowald</surname><given-names>M</given-names></name><name><surname>Younger</surname><given-names>J</given-names></name><name><surname>Pack</surname><given-names>AI</given-names></name></person-group><article-title>Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning</article-title><source>Sleep</source><year>2007</year><volume>30</volume><fpage>711</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">17580592</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YF</given-names></name><name><surname>Hang</surname><given-names>LW</given-names></name><name><surname>Huang</surname><given-names>CS</given-names></name><name><surname>Liang</surname><given-names>SJ</given-names></name><name><surname>Chung</surname><given-names>WS</given-names></name></person-group><article-title>Polysomnographic predictors of persistent continuous positive airway pressure adherence in patients with moderate and severe obstructive sleep apnea</article-title><source>Kaohsiung J Med Sci</source><year>2015</year><volume>31</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.kjms.2014.11.004</pub-id><pub-id pub-id-type="pmid">25645986</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>ZJ</given-names></name><name><surname>Zhuge</surname><given-names>Y</given-names></name><name><surname>Velazquez</surname><given-names>OC</given-names></name></person-group><article-title>Trafficking and differentiation of mesenchymal stem cells</article-title><source>J Cell Biochem</source><year>2009</year><volume>106</volume><fpage>984</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1002/jcb.22091</pub-id><pub-id pub-id-type="pmid">19229871</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanden Berg-Foels</surname><given-names>WS</given-names></name></person-group><article-title>In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment</article-title><source>Tissue Eng Part B Rev</source><year>2014</year><volume>20</volume><fpage>28</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1089/ten.TEB.2013.0100</pub-id><pub-id pub-id-type="pmid">23678952</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggenhofer</surname><given-names>E</given-names></name><name><surname>Luk</surname><given-names>F</given-names></name><name><surname>Dahlke</surname><given-names>MH</given-names></name><name><surname>Hoogduijn</surname><given-names>MJ</given-names></name></person-group><article-title>The life and fate of mesenchymal stem cells</article-title><source>Front Immunol</source><year>2014</year><volume>5</volume><fpage>148</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00148</pub-id><pub-id pub-id-type="pmid">24904568</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Becker</surname><given-names>A</given-names></name><name><surname>Riet</surname><given-names>IV</given-names></name></person-group><article-title>Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?</article-title><source>World J Stem Cells</source><year>2016</year><volume>8</volume><fpage>73</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.4252/wjsc.v8.i3.73</pub-id><pub-id pub-id-type="pmid">27022438</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreras</surname><given-names>A</given-names></name><name><surname>Almendros</surname><given-names>I</given-names></name><name><surname>Acerbi</surname><given-names>I</given-names></name><name><surname>Montserrat</surname><given-names>JM</given-names></name><name><surname>Navajas</surname><given-names>D</given-names></name><name><surname>Farr&#x000e9;</surname><given-names>R</given-names></name></person-group><article-title>Obstructive apneas induce early release of mesenchymal stem cells into circulating blood</article-title><source>Sleep</source><year>2009</year><volume>32</volume><fpage>117</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">19189787</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreras</surname><given-names>A</given-names></name><name><surname>Almendros</surname><given-names>I</given-names></name><name><surname>Montserrat</surname><given-names>JM</given-names></name><name><surname>Navajas</surname><given-names>D</given-names></name><name><surname>Farr&#x000e9;</surname><given-names>R</given-names></name></person-group><article-title>Mesenchymal stem cells reduce inflammation in a rat model of obstructive sleep apnea</article-title><source>Respir Physiol Neurobiol</source><year>2010</year><volume>172</volume><fpage>210</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.resp.2010.05.020</pub-id><pub-id pub-id-type="pmid">20594932</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreras</surname><given-names>A</given-names></name><name><surname>Rojas</surname><given-names>M</given-names></name><name><surname>Tsapikouni</surname><given-names>T</given-names></name><name><surname>Montserrat</surname><given-names>JM</given-names></name><name><surname>Navajas</surname><given-names>D</given-names></name><name><surname>Farr&#x000e9;</surname><given-names>R</given-names></name></person-group><article-title>Obstructive apneas induce early activation of mesenchymal stem cells and enhancement of endothelial wound healing</article-title><source>Respir Res</source><year>2010</year><volume>11</volume><fpage>91</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-11-91</pub-id><pub-id pub-id-type="pmid">20604943</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garreta</surname><given-names>E</given-names></name><name><surname>Nunez</surname><given-names>M</given-names></name><name><surname>Dalmases</surname><given-names>M</given-names></name><name><surname>Farre</surname><given-names>R</given-names></name><name><surname>Montserrat</surname><given-names>J</given-names></name><name><surname>Embid</surname><given-names>C</given-names></name></person-group><article-title>Mesenchymal Stem Cells In Peripheral Blood In Obstructive Sleep Apnea Syndrome Patients</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>187</volume><fpage>A3468</fpage><pub-id pub-id-type="doi">10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3468</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>P</given-names></name><name><surname>Rubies</surname><given-names>C</given-names></name><name><surname>Torres</surname><given-names>M</given-names></name><name><surname>Batlle</surname><given-names>M</given-names></name><name><surname>Farre</surname><given-names>R</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Montserrat</surname><given-names>JM</given-names></name><name><surname>Almendros</surname><given-names>I</given-names></name><name><surname>Mont</surname><given-names>L</given-names></name></person-group><article-title>Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells</article-title><source>Respir Res</source><year>2014</year><volume>15</volume><fpage>54</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-15-54</pub-id><pub-id pub-id-type="pmid">24775918</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>XF</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>FJ</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>QQ</given-names></name><name><surname>Ge</surname><given-names>RL</given-names></name><name><surname>Wang</surname><given-names>LS</given-names></name></person-group><article-title>MiRNA-486 regulates angiogenic activity and survival of mesenchymal stem cells under hypoxia through modulating Akt signal</article-title><source>Biochem Biophys Res Commun</source><year>2016</year><volume>470</volume><fpage>670</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.01.084</pub-id><pub-id pub-id-type="pmid">26801559</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burlacu</surname><given-names>A</given-names></name><name><surname>Grigorescu</surname><given-names>G</given-names></name><name><surname>Rosca</surname><given-names>AM</given-names></name><name><surname>Preda</surname><given-names>MB</given-names></name><name><surname>Simionescu</surname><given-names>M</given-names></name></person-group><article-title>Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro</article-title><source>Stem Cells Dev</source><year>2013</year><volume>22</volume><fpage>643</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1089/scd.2012.0273</pub-id><pub-id pub-id-type="pmid">22947186</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohd Ali</surname><given-names>N</given-names></name><name><surname>Boo</surname><given-names>L</given-names></name><name><surname>Yeap</surname><given-names>SK</given-names></name><name><surname>Ky</surname><given-names>H</given-names></name><name><surname>Satharasinghe</surname><given-names>DA</given-names></name><name><surname>Liew</surname><given-names>WC</given-names></name><name><surname>Ong</surname><given-names>HK</given-names></name><name><surname>Cheong</surname><given-names>SK</given-names></name><name><surname>Kamarul</surname><given-names>T</given-names></name></person-group><article-title>Probable impact of age and hypoxia on proliferation and microRNA expression profile of bone marrow-derived human mesenchymal stem cells</article-title><source>PeerJ</source><year>2016</year><volume>4</volume><fpage>e1536</fpage><pub-id pub-id-type="doi">10.7717/peerj.1536</pub-id><pub-id pub-id-type="pmid">26788424</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majumdar</surname><given-names>MK</given-names></name><name><surname>Keane-Moore</surname><given-names>M</given-names></name><name><surname>Buyaner</surname><given-names>D</given-names></name><name><surname>Hardy</surname><given-names>WB</given-names></name><name><surname>Moorman</surname><given-names>MA</given-names></name><name><surname>McIntosh</surname><given-names>KR</given-names></name><name><surname>Mosca</surname><given-names>JD</given-names></name></person-group><article-title>Characterization and functionality of cell surface molecules on human mesenchymal stem cells</article-title><source>J Biomed Sci</source><year>2003</year><volume>10</volume><fpage>228</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1007/BF02256058</pub-id><pub-id pub-id-type="pmid">12595759</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tse</surname><given-names>WT</given-names></name><name><surname>Pendleton</surname><given-names>JD</given-names></name><name><surname>Beyer</surname><given-names>WM</given-names></name><name><surname>Egalka</surname><given-names>MC</given-names></name><name><surname>Guinan</surname><given-names>EC</given-names></name></person-group><article-title>Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation</article-title><source>Transplantation</source><year>2003</year><volume>75</volume><fpage>389</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1097/01.TP.0000045055.63901.A9</pub-id><pub-id pub-id-type="pmid">12589164</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klyushnenkova</surname><given-names>E</given-names></name><name><surname>Mosca</surname><given-names>JD</given-names></name><name><surname>Zernetkina</surname><given-names>V</given-names></name><name><surname>Majumdar</surname><given-names>MK</given-names></name><name><surname>Beggs</surname><given-names>KJ</given-names></name><name><surname>Simonetti</surname><given-names>DW</given-names></name><name><surname>Deans</surname><given-names>RJ</given-names></name><name><surname>McIntosh</surname><given-names>KR</given-names></name></person-group><article-title>T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression</article-title><source>J Biomed Sci</source><year>2005</year><volume>12</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">15864738</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Nicola</surname><given-names>M</given-names></name><name><surname>Carlo-Stella</surname><given-names>C</given-names></name><name><surname>Magni</surname><given-names>M</given-names></name><name><surname>Milanesi</surname><given-names>M</given-names></name><name><surname>Longoni</surname><given-names>PD</given-names></name><name><surname>Matteucci</surname><given-names>P</given-names></name><name><surname>Grisanti</surname><given-names>S</given-names></name><name><surname>Gianni</surname><given-names>AM</given-names></name></person-group><article-title>Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli</article-title><source>Blood</source><year>2002</year><volume>99</volume><fpage>3838</fpage><lpage>3843</lpage><pub-id pub-id-type="doi">10.1182/blood.V99.10.3838</pub-id><pub-id pub-id-type="pmid">11986244</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>S</given-names></name><name><surname>Pittenger</surname><given-names>MF</given-names></name></person-group><article-title>Human mesenchymal stem cells modulate allogeneic immune cell responses</article-title><source>Blood</source><year>2005</year><volume>105</volume><fpage>1815</fpage><lpage>1822</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-04-1559</pub-id><pub-id pub-id-type="pmid">15494428</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>XX</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>SX</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>XD</given-names></name><name><surname>Mao</surname><given-names>N</given-names></name></person-group><article-title>Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells</article-title><source>Blood</source><year>2005</year><volume>105</volume><fpage>4120</fpage><lpage>4126</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-02-0586</pub-id><pub-id pub-id-type="pmid">15692068</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corcione</surname><given-names>A</given-names></name><name><surname>Benvenuto</surname><given-names>F</given-names></name><name><surname>Ferretti</surname><given-names>E</given-names></name><name><surname>Giunti</surname><given-names>D</given-names></name><name><surname>Cappiello</surname><given-names>V</given-names></name><name><surname>Cazzanti</surname><given-names>F</given-names></name><name><surname>Risso</surname><given-names>M</given-names></name><name><surname>Gualandi</surname><given-names>F</given-names></name><name><surname>Mancardi</surname><given-names>GL</given-names></name><name><surname>Pistoia</surname><given-names>V</given-names></name><etal/></person-group><article-title>Human mesenchymal stem cells modulate B-cell functions</article-title><source>Blood</source><year>2006</year><volume>107</volume><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-07-2657</pub-id><pub-id pub-id-type="pmid">16141348</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>DJ</given-names></name><name><surname>Bertoncello</surname><given-names>I</given-names></name><name><surname>Borok</surname><given-names>Z</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Panoskaltsis-Mortari</surname><given-names>A</given-names></name><name><surname>Reynolds</surname><given-names>S</given-names></name><name><surname>Rojas</surname><given-names>M</given-names></name><name><surname>Stripp</surname><given-names>B</given-names></name><name><surname>Warburton</surname><given-names>D</given-names></name><name><surname>Prockop</surname><given-names>DJ</given-names></name></person-group><article-title>Stem cells and cell therapies in lung biology and lung diseases</article-title><source>Proc Am Thorac Soc</source><year>2011</year><volume>8</volume><fpage>223</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1513/pats.201012-071DW</pub-id><pub-id pub-id-type="pmid">21653527</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>DJ</given-names></name><name><surname>Bates</surname><given-names>JH</given-names></name><name><surname>Gilbert</surname><given-names>T</given-names></name><name><surname>Liles</surname><given-names>WC</given-names></name><name><surname>Lutzko</surname><given-names>C</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name><name><surname>Prockop</surname><given-names>D</given-names></name></person-group><article-title>Stem cells and cell therapies in lung biology and diseases: conference report</article-title><source>Ann Am Thorac Soc</source><year>2013</year><volume>10</volume><fpage>S25</fpage><lpage>S44</lpage><pub-id pub-id-type="doi">10.1513/AnnalsATS.201304-089AW</pub-id><pub-id pub-id-type="pmid">23869447</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>DJ</given-names></name><name><surname>Chambers</surname><given-names>D</given-names></name><name><surname>Giangreco</surname><given-names>A</given-names></name><name><surname>Keating</surname><given-names>A</given-names></name><name><surname>Kotton</surname><given-names>D</given-names></name><name><surname>Lelkes</surname><given-names>PI</given-names></name><name><surname>Wagner</surname><given-names>DE</given-names></name><name><surname>Prockop</surname><given-names>DJ</given-names></name></person-group><article-title>An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases</article-title><source>Ann Am Thorac Soc</source><year>2015</year><volume>12</volume><fpage>S79</fpage><lpage>S97</lpage><pub-id pub-id-type="doi">10.1513/AnnalsATS.201502-086ST</pub-id><pub-id pub-id-type="pmid">25897748</pub-id></element-citation></ref></ref-list></back></article>